MOUNTAIN VIEW, Calif., Apr 9, 2012 (GlobeNewswire via COMTEX) — The US Food and Drug Administration (FDA) informed VIVUS (NASDAQ:VVUS) of an extended Prescription Drug User Fee Act (PDUFA) date for its review of the Qnexa New Drug Application (NDA) …
See all stories on this topic ยป
Related Blogs
We LOVE you so.. how about liking us on Facebook?..
Powered By Facebook Like Post Plugin
Leave a Reply